Volta

THE LEGAL IMPLICATION OF COMPULSORY LICENCE PHARMACEUTICAL PRODUCTS IN THE TRIPs AGREEMENT TO THE PROTECTION OF THE RIGHT TO HEALTH IN DEVELOPING COUNTRIES

Unknown authors · 2018
hash_id: 8ffc53914a24c23f46b3c350eefb55e5930a9b3e01743bc57b16fae9d64cdf25 · DOI: 10.20884/1.jdh.2018.18.1.1685

Compulsory license of pharmaceutical products in the Trade Related Aspects of Intellectual Property Rights (TRIPs) Agreement attempts to balance the interest of patent holders and The right to health. The access of medicines in developing countries for the epidemic diseases, such as, HIV/AIDS medicine is crucial to protect The right to health. The objective of the research is to analyze comprehensively the legal implication of compulsory license for the pharmaceutical product to the protection of The right to health in developing countries. It is a normative juridical research by applying conceptual and comparative approaches. The results of the research shows that: first, the implementation of compulsory licence is in accordance with the international human right law: second, the legal implication …

Reference & gravity metrics

Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP

Secondary-market trade history

No secondary-market trades recorded for this Volta yet.

References (0)

No outbound references recorded.

Cited by (1)

Raising the Right to Health Concerns within the Framework of International Inte… secondary